Lakewood-Amedex Biotherapeutics Highlights Nu-3 Resistance Data in Response to National Action Plan of Presidential Advisory Council on Combating Antibiotic Resistant Bacteria

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/21/2026

1. SPY
2. WBD
3. PSKY
4. NVDA
5. TSLA
6. USO
7. AMD
8. COHR
9. META
10. AMC

Go back to Lakewood-Amedex Biotherapeutics Highlights Nu-3 Resistance Data in Response to National Action Plan of Presidential Advisory Council on Combating Antibiotic Resistant Bacteria
(NASDAQ: LABT) Delayed: 2.05 +0.06 (3.02%)
Previous Close $1.99    52 Week High $ 
Open $1.99    52 Week Low $ 
Day High $2.08    P/E N/A 
Day Low $1.92    EPS $ 
Volume 362,561       

(NASDAQ: LABT) Delayed: 2.05 +0.06 (3.02%)
Previous Close $1.99    52 Week High $ 
Open $1.99    52 Week Low $ 
Day High $2.08    P/E N/A 
Day Low $1.92    EPS $ 
Volume 362,561